degrees Celsius – Talk Bio

Actionable Insights Powered by AI

AbbVie Acquires Celsius Therapeutics for $250 Million, Expanding Inflammatory Disease Portfolio

10 months ago talkbio0Tagged AbbVie, Acquisition (action), biotech, degrees Celsius, Inflammatory disorder, M&A

AbbVie, Celsius Therapeutics, Acquisition, Inflammatory Diseases, M&A, Biotech